Literature DB >> 14551291

Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo.

Keisuke Takeshita1, Katsuya Sakai, Kevin B Bacon, Florian Gantner.   

Abstract

The recently identified histamine receptor, H4, was shown to be primarily expressed on leukocytes and has been implicated in the activation of lymphocytes, eosinophils, and mast cells in vitro. Its function in vivo, however, has not yet been characterized. We present evidence for a critical role of H4 receptor in the mast cell-dependent recruitment of neutrophils. Mice injected with zymosan into the pleural cavity developed massive neutrophilia within hours after challenge. Neutrophilia was dose-dependently reduced when mice were pretreated with thioperamide, a known H(3/4) receptor antagonist, whereas H1 and H2 receptor antagonists lacked efficacy. Similarly, a 70 to 80% reduction in neutrophils in the pleural cavity compared with wild-type animals was noted in mice lacking mast cells (W/W(v) mice); mice deficient in MyD88 (MyD88(-/-)); a critical component of the signaling cascade of the major receptor for zymosan, toll-like receptor 2 (TLR2); or in mice pretreated with a functionally antagonistic anti-TLR2 antibody. The residual 20% neutrophil infiltration seen in mast cell-deficient and MyD88(-/-) mice was not further reduced by thioperamide. Neutrophilia was completely restored by transferring wild-type bone marrow-derived mast cells into MyD88(-/-) or W/W(v) mice. Interestingly, when neutrophilia was evoked by carrageenan injection, mast cell depletion and thioperamide had no effect. Various inflammatory mediators were detectable in the pleural cavity of zymosan-challenged mice. Upon pretreatment with thioperamide, reduced levels of the neutrophil chemoattractant leukotriene B4 were observed, providing a mechanistic explanation for the prevention of neutrophilia by H4 receptor antagonism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551291     DOI: 10.1124/jpet.103.057489

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  25 in total

Review 1.  Histamine H₄ receptors in the gastrointestinal tract.

Authors:  A Deiteren; J G De Man; P A Pelckmans; B Y De Winter
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.

Authors:  Florence Gbahou; Ludwig Vincent; Marie Humbert-Claude; Joel Tardivel-Lacombe; Claude Chabret; Jean-Michel Arrang
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 3.  The role of histamine H4 receptor in immune and inflammatory disorders.

Authors:  E Zampeli; E Tiligada
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

4.  Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract.

Authors:  L E Sander; A Lorentz; G Sellge; M Coëffier; M Neipp; T Veres; T Frieling; P N Meier; M P Manns; S C Bischoff
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 5.  Modulation of neutrophil oxidative burst via histamine receptors.

Authors:  M Cíž; A Lojek
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

6.  Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells.

Authors:  Yukihiro Kimura; Kazuyasu Chihara; Chisato Honjoh; Kenji Takeuchi; Shota Yamauchi; Hatsumi Yoshiki; Shigeharu Fujieda; Kiyonao Sada
Journal:  J Biol Chem       Date:  2014-09-22       Impact factor: 5.157

7.  JNJ7777120 Ameliorates Inflammatory and Oxidative Manifestations in a Murine Model of Contact Hypersensitivity via Modulation of TLR and Nrf2 Signaling.

Authors:  Ahmed F Mohamed; Mohammed F El-Yamany; Fatma A El-Batrawy; Mohamed T Abdel-Aziz
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

8.  Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Authors:  B J R Whittle; C Varga; A Berko; K Horvath; A Posa; J P Riley; K A Lundeen; A M Fourie; P J Dunford
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

9.  H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells.

Authors:  Anne-France Petit-Bertron; François Machavoine; Marie Paule Defresne; Michel Gillard; Pierre Chatelain; Prakash Mistry; Elke Schneider; Michel Dy
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

Review 10.  Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.

Authors:  Philippe Devillier; Nicolas Roche; Christophe Faisy
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.